Improving drug treatments with natural products

May 25, 2018 by Jane Icke, University of Nottingham
Improving drug treatments with natural products
Credit: University of Nottingham

Turmeric, shrimp shells, beeswax and cocoa butter are being used to improve the effectiveness of drugs and reduce side effects when treating a range of diseases including cancer and diabetes.

Research is being carried out at the University of Nottingham Malaysia to discover how these 'natural products' can improve the ways drugs are delivered and their efficiency, whilst also minimising any effects.

The team led by Professor Nashiru Billa in the School of Pharmacy has been studying curcumin from turmeric and are looking into developing ways to deliver this effectively in dosage forms to treat , specifically targeting tumour cells with minimal side effects unlike with conventional chemotherapy.

Turmeric to improve treatment for Colon Cancer

Professor Billa explains: "We are mainly using natural molecules such as turmeric, chitosan from crab or shrimp shell, and pectin from the rind of orange in the construction of the delivery system. This 'natural product' is ideal as it is biocompatible, biodegradable and muco-adhesive, which means it sticks to the surfaces of the colon intestine. We then package these components in and deliver it to the colon where it will act locally.

"One of the issues with the treatment of currently is that there is a very negative impact in the treatment due to the intense side effects of the chemotherapeutic agents. The fact that we are using curcumin means that the side effects are reduced significantly as it can be packaged in a way that specifically targets just the cancer cells in the colon and not healthy tissue. This is achieved by attaching antibodies on the surfaces of the nanoparticles that recognise and are attracted to colon cancer tissue. Furthermore, pectin also has anticancer properties when modified, as we have done here so that the effects of curcumin are reinforced."

Nanoparticles are of the order of one billionth of a meter and are the tiniest of all delivery systems. They are constructed in our labs by admixture of chitosan, pectin, curcumin and a cross-linker which knits the components into nanoparticles. The nanoparticles have the ability to penetrate the cancer tissue after recognition and carry the curcumin cargo along.

Reducing toxic side effects

The research team is also investigating reducing the that occur with an antifungal medication called Amphotericin B that is given to treat serious diseases caused by fungus such as Sepsis, Pneumonia and Meningitis. This medication is currently given intravenously but can cause kidney and heart problems.

Using cocoa butter and beeswax the scientists are developing a pill that can effectively deliver anti-fungal medication into the bloodstream via the GI tract with less toxic side effects. Professor Billa said: "We have used components such as beeswax and to act as a vehicle to produce nanoparticles that improves the bioavailbilty of Amphotericin B. We are also trying to improve the uptake of the drug by slowing its transit in the gastrointestinal tract. To do this we apply a coating of chitosan on the surface of the nanoparticles. The idea is to try and increase its transit time and by doing so we can ensure that there is maximum uptake of the drug into the blood."

Better release of medicine

Another project that incorporates the use of chitosan is aiming to create a diabetic system that responds to the glucose level in the blood. This system will use microparticles that expand when they come into contact with glucose and then respond by releasing insulin. The research team are aiming to develop a system that can be embedded under the skin, that releases the insulin gradually over time reducing the need for daily injections.

Professor Billa concludes: "All of the work we are doing is finding new frontiers in drug delivery and is completely new. Most delivery solutions being developed are based on nanoparticular systems because these have capabilities that cannot be found in the current conventional systems. The natural approach we are taking in this research is unique and the benefits will not only be for the patient, but also provides a cost effective solution for the pharmaceutical industry."

Explore further: Plant compounds give '1-2' punch to colon cancer

Related Stories

Plant compounds give '1-2' punch to colon cancer

July 22, 2016
The combination of two plant compounds that have medicinal properties - curcumin and silymarin - holds promise in treating colon cancer, according Saint Louis University research published in the June 23 issue of the Journal ...

Magnet-based drug delivery system shows promise for cancer treatment

February 2, 2018
A team of researchers at the University of Georgia has developed a non-invasive method of delivering drugs directly to cancerous tissue using magnetic forces, a form of treatment that could significantly reduce the toxic ...

Turmeric might be 'the right spice' to fight colon cancer

March 2, 2011
Turmeric, a bright yellow spice from south Asia belonging to the ginger family, is the main ingredient in curries — and ancient wisdom suggests that it's also good for your health. Taking this wisdom to the laboratory, ...

Curcumin proved effective at combating cancer

March 16, 2015
WA scientists have helped re-affirm that curcumin, a chemical compound found in turmeric, is a safe and promising treatment for most cancers and other inflammation-driven diseases.

Nanoparticles loaded with component of common spice kill cancer cells

July 25, 2017
Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells, according to a new study published in Nanoscale.

Nanoparticles target and kill cancer stem cells that drive tumor growth

June 10, 2015
Many cancer patients survive treatment only to have a recurrence within a few years. Recurrences and tumor spreading are likely due to cancer stem cells that can be tough to kill with conventional cancer drugs. But now researchers ...

Recommended for you

Discovery of inner ear function may improve diagnosis of hearing impairment

October 15, 2018
Results from a research study published in Nature Communications show how the inner ear processes speech, something that has until now been unknown. The authors of the report include researchers from Linköping University, ...

Team's study reveals hidden lives of medical biomarkers

October 12, 2018
What do medical biomarkers do on evenings and weekends, when they might be considered off the clock?

Widespread errors in 'proofreading' cause inherited blindness

October 12, 2018
Mistakes in "proofreading" the genetic code of retinal cells is the cause of a form of inherited blindness, retinitis pigmentosa (RP) caused by mutations in splicing factors.

Researchers create a functional salivary gland organoid

October 11, 2018
A research group led by scientists from Showa University and the RIKEN Center for Biosystems Dynamics Research in Japan have, for the first time, succeeded in growing three-dimensional salivary gland tissue that, when implanted ...

Lassa fever vaccine shows promise and reveals new test for immunity

October 11, 2018
Lassa fever belongs to the same class of hemorrhagic fevers as Ebola. Like Ebola, it has been a major health threat in Western Africa, infecting 100,000-300,000 people and killing 5,000 per year. A new vaccine against both ...

Genetically engineered 3-D human muscle transplant in a murine model

October 10, 2018
A growing need for tissues and organs in surgical reconstruction is addressed by the promising field of tissue engineering. For instance, muscle atrophy results from severe traumatic events including deep burns and cancer, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.